| 鐩綍鍙饵br/>Serial |
TCHu237 |
| 鏍囪瘑绗?br/>Identifier |
CSTR:19375.09.3101HUMTCHu237 |
鎻忚堪
Description |
LS513鏄竴涓粨鐩磋偁鐧岀粏鑳炴牚锛?985骞翠粠涓€浣嶈瘖鏂负Dukes' C绮樻恫鍒嗘硨鐩茶偁鑲跨槫鐨?3宀佺櫧浜虹敺鎬ф偅鑰呯殑Bauhin闃€鑲跨槫鍘熶綅娲绘涓缓鏍€侟/span> |
鍔ㄧ墿绉嶅埆
Organism |
浜裹/span> |
鎬у埆
Gender |
鐢饵/span> |
缁勭粐鏉ユ簮
Tissue and Cell Type |
鐩茶偁 |
| 褰㈡€?br/>Morphology |
涓婄毊缁嗚優 |
| 鍩瑰吇鍩哄拰娣诲姞鍓侟br/>Complete Growth Medium and Culture Conditions |
RPMI 1640鍩瑰吇鍩?GIBCO by life technologies ,璐у彿C11875500BT)锛?0%锛涗紭璐ㄨ儙鐗涜娓咃紝10%銆侟br/>姘旂浉锛氱┖姘旓紝95%锛涗簩姘у寲纰筹紝5%銆侟br/>娓╁害锛?7鎽勬皬搴︺€侟/span> |
渚涘簲闄愬埗
Permits and Restrictions |
A銆備粎渚涚爺绌朵箣鐢ㄣ€侟/span> |
| REFERENCE |
Suardet L, et al. Responsiveness of three newly established human colorectal cancer cell lines to transforming growth factors beta 1 and beta 2. Cancer Res. 52: 3705-3712, 1992. PubMed: 1617643 Burmester JK, et al. Characterization of distinct functional domains of transforming growth factor beta. Proc. Natl. Acad. Sci. USA 90: 8628-8632, 1993. PubMed: 7690965 Li CY, et al. Potential role of WAF1/Cip1/p21 as a mediator of TGF-beta cytoinhibitory effect. J. Biol. Chem. 270: 4971-4974, 1995. PubMed: 7890601 |
鍦ㄧ嚎鐣欒█
